Absci vs Surrozen
Surrozen reported revenue of $4 million in fiscal 2025, 1.2 times Absci's $3 million in fiscal 2025. Absci's revenue fell 38.2% in its latest year, and Surrozen's fell 67.4%. Absci had an operating margin of -4297.0%, against -1210.6% at Surrozen. Free cash flow was −$94 million at Absci and −$30 million at Surrozen.
Side by side
| Absci | Surrozen | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $3M | $4M |
| Revenue growth | −38.2% | −67.4% |
| Revenue growth a year, last 5 years | −10.2% | — |
| Gross margin | — | — |
| Operating margin | −4,297.0% | −1,210.6% |
| Net margin | −4,113.7% | −6,960.8% |
| Free cash flow | −$94M | −$30M |
| Free cash flow margin | −3,358.3% | −873.5% |
| Return on capital | −162.8% | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 24.1% | 155.0% |
| Last close | $8.16 | $30.67 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $933,174, sold $132,328 | bought $6.9 million, sold $7.2 million |
| Piotroski F-score | 3 of 8 | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
AbsciSurrozen
Operating margin
Percent of revenue
AbsciSurrozen
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AbsciSurrozen